Clinical Trial

Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the potential benefit of an oral nutritional supplement based on CRONILIEF™ (Palmitoylethanolamide Phospholipids) in diabetic subjects with neuropathic pain, compared to a placebo.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-22.
Trial Details
NCT Number NCT07377409
Lead Sponsor Azienda di Servizi alla Persona di Pavia
Conditions Neuropathic Pain Management, Diabetic Neuropathies, Painful, Palmitoylethanolamide
Enrollment 70 participants
Start Date 2026-09-15
Primary Completion 2026-12-15 (estimated)
Study Completion 2027-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-17